Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia
- 1 October 1985
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 34 (10) , 978-981
- https://doi.org/10.1016/0026-0495(85)90149-0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Treatment of type III hyperlipoproteinemia with four different treatment regimensAtherosclerosis, 1984
- The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.Circulation, 1984
- Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.Circulation, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol loweringJAMA, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984
- Familial hyperlipoproteinemia type III: Deficiency of a specific apolipoprotein (APO E‐III) in the very‐low‐density lipoproteinsFEBS Letters, 1975
- Improved Techniques for Assessment of Serum Lipoprotein Patterns. II. Rapid Method for Diagnosis of Type III Hyperlipoproteinemia without UltracentrifugationClinical Chemistry, 1973
- Dietary and Drug Treatment of Primary HyperlipoproteinemiaAnnals of Internal Medicine, 1972